CSTL has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. CSTL ranks #438 in insider activity out of 563 tracked companies in its industry.
Insider Trading Summary & Commentary
Automated executive transaction analysis for CSTL
Over the last 90 days, corporate insiders at CSTL (CSTL) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 54 were sales. The total volume of insider trading reached $17.83M.
The net insider activity for CSTL shows a net selling bias of $17.83M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Maetzold Derek J (Pres, Chief Exec. Officer), who traded 32.3K shares valued at $1.25M on Dec 15, 2025.
Live Market News & Developments
Aggregated real-time headlines for CSTL (CSTL)
6 updates
Castle Biosciences Stock Price Forecast. Should You Buy CSTL?
StockInvest.us5d ago
Castle Biosciences, Inc. (CSTL) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance14d ago
Derek Maetzold, Castle Biosciences CEO, sells $228,530 in shares By Investing.com
Investing.com UK1h ago
CSTL Forecast — Price Target — Prediction for 2027
TradingView147d ago
Castle Biosciences (CSTL) Stock Dropped, So What Is Behind The Fresh Attention?
Simply Wall St11d ago
Castle Biosciences (NASDAQ:CSTL) Stock Price Target Raised at KeyCorp
MarketBeat13d ago
FAQs About CSTL Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for CSTL.
Based on SEC Form 4 disclosures, the Insider Confidence Score for CSTL is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 54 sales by company executives over the last 90 days.
The CEO Conviction Index for CSTL is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.
No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.